- Home
- ECOR vs BCG Comparison
ECOR vs BCG Comparison
Compare ECOR & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- BCG
- Stock Information
- Founded
- ECOR 2005
- BCG 2016
- Country
- ECOR United States
- BCG United States
- Employees
- ECOR N/A
- BCG N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BCG
- Sector
- ECOR Health Care
- BCG
- Exchange
- ECOR Nasdaq
- BCG Nasdaq
- Market Cap
- ECOR 50.1M
- BCG 41.3M
- IPO Year
- ECOR 2018
- BCG N/A
- Fundamental
- Price
- ECOR $6.11
- BCG $2.07
- Analyst Decision
- ECOR Strong Buy
- BCG
- Analyst Count
- ECOR 2
- BCG 0
- Target Price
- ECOR $25.50
- BCG N/A
- AVG Volume (30 Days)
- ECOR 71.2K
- BCG 9.1K
- Earning Date
- ECOR 08-06-2025
- BCG 08-14-2025
- Dividend Yield
- ECOR N/A
- BCG N/A
- EPS Growth
- ECOR N/A
- BCG N/A
- EPS
- ECOR N/A
- BCG N/A
- Revenue
- ECOR $26,458,000.00
- BCG $172,860,000.00
- Revenue This Year
- ECOR $23.21
- BCG N/A
- Revenue Next Year
- ECOR $44.10
- BCG N/A
- P/E Ratio
- ECOR N/A
- BCG N/A
- Revenue Growth
- ECOR 41.54
- BCG 7.36
- 52 Week Low
- ECOR $4.47
- BCG $1.71
- 52 Week High
- ECOR $19.49
- BCG $6.55
- Technical
- Relative Strength Index (RSI)
- ECOR 62.63
- BCG N/A
- Support Level
- ECOR $5.13
- BCG N/A
- Resistance Level
- ECOR $5.69
- BCG N/A
- Average True Range (ATR)
- ECOR 0.42
- BCG 0.00
- MACD
- ECOR 0.09
- BCG 0.00
- Stochastic Oscillator
- ECOR 91.27
- BCG 0.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.